Ocuphire Pharma, Inc. Quarterly Depreciation in USD from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Ocuphire Pharma, Inc. quarterly/annual Depreciation history and growth rate from Q2 2011 to Q2 2024.
  • Ocuphire Pharma, Inc. Depreciation for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
  • Ocuphire Pharma, Inc. Depreciation for the twelve months ending June 30, 2024 was $4K, unchanged year-over-year.
  • Ocuphire Pharma, Inc. annual Depreciation for 2023 was $6K, a 50% increase from 2022.
  • Ocuphire Pharma, Inc. annual Depreciation for 2022 was $4K, unchanged from 2021.
  • Ocuphire Pharma, Inc. annual Depreciation for 2021 was $4K, a 50% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $4K $0 -$1K -100% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $5K $0 -$1K -100% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $6K $3K +$2K +200% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 $4K $1K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $4K $1K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $4K $1K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $4K $1K $0 0% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 $4K $1K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $4K $1K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $4K $1K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $4K $1K $0 0% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $4K $1K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $4K $1K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $4K $1K -$4K -80% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $8K $1K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 $1K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $1K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $5K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q3 2015 $25.8K $7.3K +$3.55K +94.9% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-02
Q2 2015 $22.3K $6.48K -$3.15K -32.7% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $25.4K $6.17K -$2.88K -31.8% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $28.3K $5.91K -$3.03K -33.9% Oct 1, 2014 Dec 31, 2014 10-K 2015-03-16
Q3 2014 $31.4K $3.74K -$5.9K -61.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 $37.3K $9.63K +$395 +4.28% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $36.9K $9.04K -$272 -2.92% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $37.1K $8.94K -$1.29K -12.6% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 $38.4K $9.65K -$1.08K -10% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $39.5K $9.24K -$1.49K -13.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 $41K $9.32K -$1.41K -13.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 $42.4K $10.2K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-21
Q3 2012 $10.7K +$594 +5.87% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 $10.7K +$71.00 +0.67% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-12
Q1 2012 $10.7K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q3 2011 $10.1K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $10.7K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.